$66.00
0.77% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US03940C1009
Symbol
ACLX
Sector
Industry

Arcellx Stock price

$66.00
+7.75 13.30% 1M
-17.80 21.24% 6M
-10.69 13.94% YTD
+10.21 18.30% 1Y
+51.00 340.00% 5Y
+51.00 340.00% 10Y
+51.00 340.00% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.51 0.77%
ISIN
US03940C1009
Symbol
ACLX
Sector
Industry

Key metrics

Market capitalization $3.64b
Enterprise Value $3.09b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 40.28
P/S ratio (TTM) P/S ratio 47.35
P/B ratio (TTM) P/B ratio 8.72
Revenue growth (TTM) Revenue growth -41.66%
Revenue (TTM) Revenue $76.81m
EBIT (operating result TTM) EBIT $-190.66m
Free Cash Flow (TTM) Free Cash Flow $-122.49m
Cash position $543.27m
EPS (TTM) EPS $-2.93
P/E forward negative
P/S forward 53.83
EV/Sales forward 45.79
Short interest 16.58%
Show more

Is Arcellx a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Arcellx Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Arcellx forecast:

18x Buy
100%

Analyst Opinions

18 Analysts have issued a Arcellx forecast:

Buy
100%

Financial data from Arcellx

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
77 77
42% 42%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 92 92
25% 25%
120%
- Research and Development Expense 176 176
32% 32%
229%
-185 -185
154% 154%
-240%
- Depreciation and Amortization 5.94 5.94
140% 140%
8%
EBIT (Operating Income) EBIT -191 -191
153% 153%
-248%
Net Profit -162 -162
221% 221%
-211%

In millions USD.

Don't miss a Thing! We will send you all news about Arcellx directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arcellx Stock News

Neutral
Business Wire
24 days ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced two upcoming investor events: TD Cowen's 6th Annual Oncology Innovation Summit Tuesday, May 27, 2025 at 9:00 a.m. PT (Virtual) Management and Physician Pr...
Neutral
Business Wire
about one month ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced new positive data from its pivotal Phase 2 iMMagine-1 study of anitocabtagene autoleucel (anito-cel), in patients with relapsed or refractory multiple mye...
Neutral
Business Wire
about one month ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today reported business highlights and financial results for the first quarter ended March 31, 2025. “Delivering therapies that can positively impact patients' lives is o...
More Arcellx News

Company Profile

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

Head office United States
CEO Rami Elghandour
Employees 130
Founded 2014
Website www.arcellx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today